GleamWall
中文EN

PGEN PRECIGEN, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1356090 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY109.9%
TTM EPS YoY107.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin21.4%
Net margin15.6%
FCF margin-47.4%
EBITDA margin23.9%

Returns

ROE38.8%
ROA12.7%
ROIC (approx.)23.5%
Asset turnover0.82x

Leverage & solvency

Liabilities / assets60.5%
Debt / equity1.12x
Current ratio5.58x
Interest coverage2.85x

Cash quality & payout

Operating cash flow / net income-3.00x
Accruals ratio50.9%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$9.68M$3.92M
R&D expense$41.33M$53.07M
SG&A expense$70.13M$41.29M
Operating income-$110.51M-$135.03M
Interest expense$3.87M$6,000
Pretax income-$250.64M-$128.03M
Income tax$3,000-$1.79M
Net income-$250.64M-$126.23M
EBITDA-$107.31M-$130.50M
EPS (basic)-1.37-0.47
EPS (diluted)-1.37-0.47
Weighted avg. shares (diluted)312.98M267.73M
Balance sheet
Cash & equivalents$30.23M$29.52M
Short-term investments$67.62M$68.39M
Receivables$3.92M$926,000
Inventory$9.58M$0
Current assets$115.23M$102.41M
PP&E, net$13.76M$13.83M
Goodwill$15.23M$19.14M
Intangibles$3.18M$4.46M
Total assets$155.50M$145.27M
Current liabilities$37.31M$21.52M
Long-term debt$93.17M$0
Total debt$93.17M$0
Total liabilities$134.59M$78.53M
Shareholders' equity$20.91M$38.51M
Net debt$62.94M-$29.52M
Shares outstanding353.91M292.87M
Cash flow statement
Operating cash flow-$87.83M-$68.17M
Capital expenditure$2.00M$8.58M
Free cash flow-$89.83M-$76.76M
Investing cash flow-$1.53M-$20.71M
Financing cash flow$90.05M$110.58M
Depreciation & amortization$3.20M$4.53M
Stock-based compensation$10.87M$9.47M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.